The discovery of causative TARDBP mutations in 2008 [5,6] brought this gene to the forefront of neurodegeneration research, not only as a major pathological marker but also as a causative factor in sporadic and familial ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.